Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120090) titled 'Clinical evaluation study on regulating qi and relieving depression to improve chest pain combined with anxiety and depression after PCI' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Provincial Hospital of Chinese Medicine
Condition:
Post-PCI chest pain combined with anxiety and/or depression symptoms
Intervention:
Treatment group:Shugan Jieyu Capsule
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-09
Target Sample Size: Treatment group:252;Control group:252;
Countries of Recruitment:
China
To know more, visit http...